Company profile
PetVivo Holdings, Inc.
OTC: PETV · Healthcare · Medical - Devices
#864 of 1,422 Healthcare companies by revenue43rd-percentile growth
EA Score
38DFH 29DQ 50GM 37SS 49
v0.1 · 65/100 weight · provisional
↑ disclosure history, balance-sheet leverage · ↓ return on equity, return on assets
Methodology →Revenue TTM
$1.1M
Rev growth YoY (TTM)
+0.8%
Net income (FY)
-$10.5M
Employees
22
as of 2026-08-21
Market cap
$26.3M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.1M$1.1M2026
Net income-$10.5M-$10.5M2026
Operating income-$9.1M-$9.1M2026
Total assets$3.6M$3.6M2026
Liabilities$1.4M$1.4M2026
Equity$2.2M$2.2M2026
Revenue trend
FY2018 – FY2026 · USD
FY18
FY20
FY21
FY22
FY23
FY24
FY25
FY26
Revenue by segment
Filed disclosures · FY2026
By product
Product0%
By geography
Not disclosed.
The read
What is PetVivo Holdings, Inc.’s revenue?
PetVivo Holdings, Inc. booked $1.1M in FY2026 revenue, growing 0.8% year over year — about the middle of the pack among Healthcare companies we track, at a -917.4% net margin.
Peers · Healthcare
SOHM, Inc.61CPeoplesway.com Inc.——Ampio Pharmaceuticals, Inc.——RenovoRx, Inc.32DBespoke Extracts, Inc.——Kaleido Biosciences, Inc.——Neighbors
Hennepin →Key facts
CEOJohn Lai
SectorHealthcare
IndustryMedical - Devices
HeadquartersMinneapolis, MN
ExchangeOTC: PETV
Employees22
IPO date2014-09-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.